Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-31 @ 1:18 AM
Study NCT ID:
NCT01025232
Status:
TERMINATED
Last Update Posted:
2017-01-02
First Post:
2009-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Sponsor:
David M. Brown, M.D.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-02
First Submit QC Date:
None
Study First Post Date:
2009-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-08
Results First Submit QC Date:
None
Results First Post Date:
2017-01-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-03
Last Update Post Date:
2017-01-02
Last Update Post Date Type:
ESTIMATED